JeffreyBradfordLowMDMBA
Other MD/DO • San Francisco, CAPrincipal, Novo Growth | Life Sciences Investor
Dr. Low is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
501 2nd Street
#300
San Francisco, CA 94107- Is this information wrong?
Clinical Expertise
- Venture Capital
Education & Training
Yale School of MedicineClass of 2015
Harvard Business SchoolMBA- Harvard UniversityAB, Molecular and Cellular Biology
Awards, Honors, & Recognition
- Forbes 30 under 30 in Venture Capital Forbes, 2019
Publications & Presentations
PubMed
- 12 citationsComparison of two independent systematic reviews of trials of recombinant human bone morphogenetic protein-2 (rhBMP-2): the Yale Open Data Access Medtronic Project.Jeffrey B. Low, Joseph S. Ross, Jessica D. Ritchie, Cary P. Gross, Richard Lehman, Haiqun Lin, Rongwei Fu, Lesley A. Stewart, Harlan M. Krumholz> ;Systematic Reviews. 2017 Feb 15
- 1 citationsMoving forward from rhBMP-2: open science and data sharing.Jeffrey B. Low, Joseph S. Ross, Harlan M. Krumholz> ;Spine. 2014 Apr 1
- 65 citationsComplications associated with the use of the recombinant human bone morphogenetic proteins for posterior interbody fusions of the lumbar spine.Jesse Chrastil, Jeffrey B. Low, Peter G. Whang, Alpesh A. Patel> ;Spine. 2013 Jul 15
- Join now to see all
Press Mentions
30 Under 30 Venture Capital 2019: These Up-and-Coming Investors Are Changing the Face of VCNovember 14th, 2018
External Links
- Websitehttp://jeffreylow.com
- a16z articleshttps://a16z.com/author/jeffrey-low/
- Novo Growthhttps://www.novoholdings.dk/people/jeffrey-low/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
